Circulating fibrosis biomarkers and risk of atrial fibrillation: The Cardiovascular Health Study (CHS).
暂无分享,去创建一个
Marlena Maziarz | Michael A Rosenberg | D. Siscovick | S. Heckbert | N. Glazer | S. Zieman | L. Djoussé | J. Ix | J. Kizer | K. Mukamal | Alex Y. Tan | David S Siscovick | Susan R Heckbert | Alex Y Tan | Nicole L Glazer | Jorge R Kizer | Kenneth J Mukamal | M. Maziarz | Joachim H Ix | Luc Djousse | M. Rosenberg | Susan J Zieman
[1] J. Risteli,et al. Rapid equilibrium radioimmunoassay for the amino-terminal propeptide of human type III procollagen. , 1988, Clinical chemistry.
[2] R. Kronmal,et al. The Cardiovascular Health Study: design and rationale. , 1991, Annals of epidemiology.
[3] M. Hori,et al. High prevalence of atrial fibrosis in patients with dilated cardiomyopathy. , 1995, Journal of the American College of Cardiology.
[4] M. Cushman,et al. Laboratory methods and quality assurance in the Cardiovascular Health Study. , 1995, Clinical chemistry.
[5] L. Kuller,et al. Methods of assessing prevalent cardiovascular disease in the Cardiovascular Health Study. , 1995, Annals of epidemiology.
[6] L H Kuller,et al. Incidence of and risk factors for atrial fibrillation in older adults. , 1997, Circulation.
[7] M. Allessie,et al. Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat. , 1997, Circulation.
[8] Robert Gray,et al. A Proportional Hazards Model for the Subdistribution of a Competing Risk , 1999 .
[9] I. Kodama,et al. Anisotropic Conduction Properties in Canine Atria Analyzed by High-Resolution Optical Mapping: Preferential Direction of Conduction Block Changes From Longitudinal to Transverse With Increasing Age , 2002, Circulation.
[10] M. Rosen,et al. Cellular electrophysiologic properties of old canine atria provide a substrate for arrhythmogenesis. , 2002, Cardiovascular research.
[11] S. Nattel,et al. Atrial Ischemia Promotes Atrial Fibrillation in Dogs , 2003, Circulation.
[12] Sander Verheule,et al. Increased Vulnerability to Atrial Fibrillation in Transgenic Mice With Selective Atrial Fibrosis Caused by Overexpression of TGF-β1 , 2004, Circulation research.
[13] P. Marino,et al. Independent and additional prognostic value of aminoterminal propeptide of type III procollagen circulating levels in patients with chronic heart failure. , 2004, Journal of cardiac failure.
[14] S. Nattel,et al. Dissociation Between Ionic Remodeling and Ability to Sustain Atrial Fibrillation During Recovery From Experimental Congestive Heart Failure , 2004, Circulation.
[15] Bruce M Psaty,et al. Fish intake and risk of incident atrial fibrillation. , 2004, Circulation.
[16] M. Capecchi,et al. Mice with cardiac-restricted angiotensin-converting enzyme (ACE) have atrial enlargement, cardiac arrhythmia, and sudden death. , 2004, The American journal of pathology.
[17] M. Rosen,et al. Age-associated changes in electrophysiologic remodeling: a potential contributor to initiation of atrial fibrillation. , 2005, Cardiovascular research.
[18] V. Shusterman,et al. Atrial contractile dysfunction, fibrosis, and arrhythmias in a mouse model of cardiomyopathy secondary to cardiac-specific overexpression of tumor necrosis factor-{alpha}. , 2005, American journal of physiology. Heart and circulatory physiology.
[19] G. Edwards,et al. Atrial electrical and structural abnormalities in an ovine model of chronic blood pressure elevation after prenatal corticosteroid exposure: implications for development of atrial fibrillation. , 2006, European heart journal.
[20] Xueli Yuan,et al. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis , 2007, Nature Medicine.
[21] T. Murohara,et al. Circulating adiponectin levels in patients with atrial fibrillation. , 2008, Circulation journal : official journal of the Japanese Circulation Society.
[22] S. Nattel,et al. Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation. , 2008, Journal of the American College of Cardiology.
[23] H. Pak,et al. Clinical and serological predictors for the recurrence of atrial fibrillation after electrical cardioversion. , 2009, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[24] Y. On,et al. Plasma transforming growth factor beta1 as a biochemical marker to predict the persistence of atrial fibrillation after the surgical maze procedure. , 2009, The Journal of thoracic and cardiovascular surgery.
[25] J. Gottdiener,et al. Association Between Elevated Fibrosis Markers and Heart Failure in the Elderly: The Cardiovascular Health Study , 2009, Circulation. Heart failure.
[26] Richard A. Kronmal,et al. N-Terminal Pro-B-Type Natriuretic Peptide Is a Major Predictor of the Development of Atrial Fibrillation: The Cardiovascular Health Study , 2009, Circulation.
[27] Ulrich Schotten,et al. Fibrillatory Conduction in the Atrial Free Walls of Goats in Persistent and Permanent Atrial Fibrillation , 2010, Circulation. Arrhythmia and electrophysiology.
[28] E. Benjamin,et al. Relations of Biomarkers of Extracellular Matrix Remodeling to Incident Cardiovascular Events and Mortality , 2010, Arteriosclerosis, thrombosis, and vascular biology.
[29] E. Kholmovski,et al. Evaluation of the left atrial substrate in patients with lone atrial fibrillation using delayed-enhanced MRI: implications for disease progression and response to catheter ablation. , 2010, Heart rhythm.
[30] M. Borggrefe,et al. Transforming growth factor beta 1 (TGF-beta 1) in atrial fibrillation and acute congestive heart failure , 2011, Clinical Research in Cardiology.
[31] M. Kawamura,et al. Candesartan Decreases Type III Procollagen-N-Peptide Levels and Inflammatory Marker Levels and Maintains Sinus Rhythm in Patients With Atrial Fibrillation , 2010, Journal of cardiovascular pharmacology.
[32] K. Jeong,et al. Frequency of vacuolating cytotoxin A (VacA)-positive Helicobacter pylori seropositivity and TGF-β1 decrease in atrial fibrillation. , 2010, International journal of cardiology.
[33] R. Kalluri,et al. The origin of fibroblasts and mechanism of cardiac fibrosis , 2010, Journal of cellular physiology.
[34] H. Pak,et al. High plasma concentrations of transforming growth factor-β and tissue inhibitor of metalloproteinase-1: potential non-invasive predictors for electroanatomical remodeling of atrium in patients with non-valvular atrial fibrillation. , 2011, Circulation journal : official journal of the Japanese Circulation Society.
[35] S. Baldus,et al. Inflammatory pathways underlying atrial fibrillation. , 2011, Trends in molecular medicine.
[36] P. Zimetbaum,et al. Atrial Fibrillation and Atrial Fibrosis , 2010, Journal of cardiovascular pharmacology.
[37] R. McKelvie,et al. Relation of Peripheral Collagen Markers to Death and Hospitalization in Patients With Heart Failure and Preserved Ejection Fraction: Results of the I-PRESERVE Collagen Substudy , 2011, Circulation. Heart failure.
[38] P. Platonov,et al. Structural abnormalities in atrial walls are associated with presence and persistency of atrial fibrillation but not with age. , 2011, Journal of the American College of Cardiology.
[39] E. Kholmovski,et al. Association of left atrial fibrosis detected by delayed-enhancement magnetic resonance imaging and the risk of stroke in patients with atrial fibrillation. , 2011, Journal of the American College of Cardiology.
[40] Chengwen Sun,et al. 20-Hydroxyeicosatetraenoic acid induces apoptosis in neonatal rat cardiomyocytes through mitochondrial-dependent pathways. , 2011, Journal of cardiovascular pharmacology.
[41] J. D. de Bakker,et al. Biomarkers of Myocardial Fibrosis , 2011, Journal of cardiovascular pharmacology.
[42] A. Capucci,et al. Subclinical atrial fibrillation and the risk of stroke. , 2012, The New England journal of medicine.
[43] Stefan L. Zimmerman,et al. Initial experience with magnetic resonance imaging of atrial scar and co-registration with electroanatomic voltage mapping during atrial fibrillation: success and limitations. , 2012, Heart rhythm.
[44] A. Reiner,et al. Transforming growth factor beta-1 and incidence of heart failure in older adults: the Cardiovascular Health Study. , 2012, Cytokine.
[45] P. Ellinor,et al. A Novel Transgenic Mouse Model of Cardiac Hypertrophy and Atrial Fibrillation. , 2012, Journal of atrial fibrillation.
[46] O. Bruyère,et al. Creatinine-or cystatin C-based equations to estimate glomerular filtration in the general population: impact on the epidemiology of chronic kidney disease , 2013, BMC Nephrology.